5 assets in Soft Tissue Neoplasm

Durvalumab

Gamma1 Heavy Chain Humanized (1-448) [Vh (Homo Sapiens Ighv3-15*07 (86.9%)--(Ighd) -Ighj1*01(90.9%), Cdr-Imgt [8.10.9] (26-33.51-60.99-107))(1-118) -Homo Sapiens Ighg1*01 (100%), G1M17,1 Ch1K120, Ch3 D12, L14 (Ch1 K120 (215) (119-216),Hinge 1-15 (217-231), Ch2 (232-341), Ch3 D12 (357), L14 (359) (342-446), Chs (447-448)) (119-448)], (221-220')-Disulfide With Kappa Light Chain Humanized (1'-220') [V-Kappa (Homo Sapiens Igkv2-24*01 (90.0%)-Igkj2*01 (100%), Cdr-Imgt [11.3.10] (27-37.55-57.94-103)) (1'-113') -Homo Sapiens Igkc*01 (100%), Km3, A45.1 (159), V101 (197) (114'-220')]; Dimer (227-227'':230-230'')-Bisdisulfide, Produced In Chinese Hamster Ovary (Cho) Cells, Derived From The Cell Line Cho-K1, Glycoform Alfa

89-zr-dfo-star polyethylene glycol

Immunoglobulin G4, Anti-(Human Programmed Cell Death Protein 1) (Human Monoclonal Regn2810 Heavy Chain), Disulfide With Human Monoclonal Regn2810 .Kappa.-Chain, Dimer

Tolododekin Alfa